Patel D, Shepherd P S, Naylor J A, McCance D J
Department of Microbiology, United Medical School Guy's Hospital, London, U.K.
J Gen Virol. 1989 Jan;70 ( Pt 1):69-77. doi: 10.1099/0022-1317-70-1-69.
Polyclonal and monoclonal antibodies have been raised against a fusion protein containing beta-galactosidase and part of the major capsid protein L1 of the human papillomavirus (HPV) type 16. The polyclonal antibodies cross-reacted with the L1 protein of several HPV types including HPV-1, -2, -6 and -11 when reacted with virus-infected tissue sections, and with HPV-6 and -18 L1 fusion proteins on Western blotting. Monoclonal antibodies against the L1 fusion protein of HPV-16 reacted only with HPV-16 L1 fusion proteins on Western blots and with HPV-16-containing biopsy sections as assessed by in situ DNA-DNA hybridization. These antibodies did not detect HPV-6 L1 protein after Western blotting or in HPV-6-infected tissue sections, although one did react with an HPV-18 fusion protein after Western blotting. The monoclonal antibodies were able to detect HPV-16 antigens in routine formaldehyde-fixed, wax-embedded sections of cervical intraepithelial neoplasia sections. HPV-16 L1 proteins were seen in one-third of biopsies that were positive using the polyclonal cross-reacting antisera. Polyclonal antibodies to fusion proteins containing part of the minor capsid protein L2 of HPV-6 or -16 appeared to be more type-specific as no cross-reactivity was seen when these antibodies were reacted with HPV-1- and -2-infected tissue sections.
已制备出针对一种融合蛋白的多克隆抗体和单克隆抗体,该融合蛋白包含β-半乳糖苷酶和人乳头瘤病毒(HPV)16型的主要衣壳蛋白L1的一部分。当与病毒感染的组织切片反应时,多克隆抗体与几种HPV类型的L1蛋白发生交叉反应,包括HPV-1、-2、-6和-11,并且在蛋白质印迹法中与HPV-6和-18 L1融合蛋白发生反应。通过原位DNA-DNA杂交评估,针对HPV-16 L1融合蛋白的单克隆抗体在蛋白质印迹中仅与HPV-16 L1融合蛋白反应,以及与含HPV-16的活检切片反应。这些抗体在蛋白质印迹后或在HPV-6感染的组织切片中未检测到HPV-6 L1蛋白,尽管有一种抗体在蛋白质印迹后与HPV-18融合蛋白发生反应。单克隆抗体能够在宫颈上皮内瘤变的常规甲醛固定、石蜡包埋切片中检测到HPV-16抗原。在使用多克隆交叉反应抗血清呈阳性的活检样本中,三分之一可见HPV-16 L1蛋白。针对包含HPV-6或-16次要衣壳蛋白L2一部分的融合蛋白的多克隆抗体似乎更具型特异性,因为当这些抗体与HPV-1和-2感染的组织切片反应时未观察到交叉反应。